Literature DB >> 30531366

Detection and management of dyspnea in mechanically ventilated patients.

Maxens Decavèle1,2, Thomas Similowski1,2, Alexandre Demoule1,2.   

Abstract

PURPOSE OF REVIEW: In ICU patients, dyspnea is one of the most prominent and distressing symptom. We sought to summarize current data on the prevalence and prognostic influence of dyspnea in the ICU setting and to provide concise and useful information for dyspnea detection and management. RECENT
FINDINGS: As opposed to pain, dyspnea has been a neglected symptom with regard to detection and management. Many factors contribute to the pathogenesis of dyspnea. Among them, ventilator settings seem to play a major role. Dyspnea affects half of mechanically ventilated patient and causes immediate intense suffering [median dyspnea visual analog scale of 5 (4-7)]. In addition, it is associated with delayed extubation and with an increased risk of intubation and mortality in those receiving noninvasive ventilation. However, one-third of critically ill patients are noncommunicative, and therefore, at high risk of misdiagnosis. Heteroevaluation scales based on physical and behavioral signs of respiratory discomfort are reliable and promising alternatives to self-report.
SUMMARY: Dyspnea is frequent and severe in critically ill patients. Implementation of observational scale will help physicians to access to noncommunicative patient's respiratory suffering and tailor its treatment. Further studies on the prognostic impact and management strategies are needed.

Entities:  

Mesh:

Year:  2019        PMID: 30531366     DOI: 10.1097/MCC.0000000000000574

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  3 in total

1.  Discomfort improvement for critically ill patients using electronic relaxation devices: results of the cross-over randomized controlled trial E-CHOISIR (Electronic-CHOIce of a System for Intensive care Relaxation).

Authors:  Lili Merliot-Gailhoustet; Chloé Raimbert; Océane Garnier; Julie Carr; Audrey De Jong; Nicolas Molinari; Samir Jaber; Gerald Chanques
Journal:  Crit Care       Date:  2022-09-03       Impact factor: 19.334

2.  Low dose of morphine to relieve dyspnea in acute respiratory failure (OpiDys): protocol for a double-blind randomized controlled study.

Authors:  Alexandre Demoule; Robin Deleris; Côme Bureau; Said Lebbah; Maxens Decavèle; Martin Dres; Thomas Similowski; Agnes Dechartres
Journal:  Trials       Date:  2022-09-30       Impact factor: 2.728

3.  Adjusting ventilator settings to relieve dyspnoea modifies brain activity in critically ill patients: an electroencephalogram pilot study.

Authors:  Mathieu Raux; Xavier Navarro-Sune; Nicolas Wattiez; Felix Kindler; Marine Le Corre; Maxens Decavele; Suela Demiri; Alexandre Demoule; Mario Chavez; Thomas Similowski
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.